17.00 - 18.00 h , Lecture Hall1, Pharmazentrum, Klingelbergstrasse 50, 4056 Basel
Dr. Peter Mohr Hoffmann-La Roche AG, Basel
Aleglitazar, a potent and balanced dual PPARalpha/gamma Agonist for the Treatment of Type II Diabetes
http://www.pharma.unibas.ch/index.php?id=seminars manuela.rogalski@unibas.ch